Report Overview

The EU Addiction Therapeutics Market size stood at around USD xx billion in 2019 and is projected to reach USD $2.14 billion by 2028, exhibiting a CAGR of xx% during the forecast period

Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individuals brain, behavior, and metabolic processes leading to an inability to control. Nonmedical use and abuse of prescription drugs are becoming severe issues. Addiction to abusive substances is responsible for the death of millions of people. The Addiction Centre report estimated that over 11% of France's population consumed cannabis at some point, and 41,000 people died due to alcohol-related causes between 2015 and 2017. The reports also stated that the number of people undertaking treatments for these addictions has increased in the recent years



Market Drivers

The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the Europe addiction therapeutics market in the coming years